Literature DB >> 21768448

The impact of physician screening on melanoma detection.

Ivanka Kovalyshyn1, Stephen W Dusza, Katherine Siamas, Allan C Halpern, Giuseppe Argenziano, Ashfaq A Marghoob.   

Abstract

OBJECTIVE: To compare melanoma characteristics and detection patterns in new vs established patients in a pigmented lesion clinic at Memorial Sloan-Kettering Cancer Center (MSKCC) during a 10-year period.
DESIGN: Single-center historical cohort study.
SETTING: Academic practice of 2 dermatologists with expertise in the management of pigmented skin lesions. PATIENTS: The study included 394 patients diagnosed with cutaneous melanoma at MSKCC between 1998 and 2008. For the purposes of this study, we separated patients into 2 groups: established patients, defined as patients who have received professional services in a pigmented lesion clinic at MSKCC for at least 3 months, vs new patients, defined as patients new to our practice. MAIN OUTCOME MEASURES: Melanoma histologic characteristics and patterns of melanoma detection in established vs new patients.
RESULTS: Established patients had more in situ disease (70% vs 57%; P < .001) and thinner invasive melanomas (0.45 mm vs 0.82 mm; P = .002) and were less likely to present with negative prognostic attributes such as ulceration and dermal mitoses compared with new patients. In new patients, 63% of melanomas were physician detected vs 82% in established patients; 18% of all melanomas were patient detected. Dermatologist-detected melanomas were thinner compared with self-detected melanomas. The majority of self-detected melanomas were noted by patients because of change (64%). The overall benign to malignant biopsy ratio over the 10-year period was 5.4:1.
CONCLUSION: Physician-based screening leads to higher rates of physician-detected melanoma and detection of thinner melanoma.

Entities:  

Mesh:

Year:  2011        PMID: 21768448     DOI: 10.1001/archdermatol.2011.181

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

1.  A Randomized Trial on the Efficacy of Mastery Learning for Primary Care Provider Melanoma Opportunistic Screening Skills and Practice.

Authors:  June K Robinson; Namita Jain; Ashfaq A Marghoob; William McGaghie; Michael MacLean; Pedram Gerami; Brittney Hultgren; Rob Turrisi; Kimberly Mallett; Gary J Martin
Journal:  J Gen Intern Med       Date:  2018-02-05       Impact factor: 5.128

2.  The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.

Authors:  Richard G Roetzheim; Ji-Hyun Lee; Jeanne M Ferrante; Eduardo C Gonzalez; Ren Chen; Kate J Fisher; Kymia Love-Jackson; Ellen P McCarthy
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

3.  Prevalence and predictors of recent skin examination in a population-based twin cohort.

Authors:  Kimberly A Miller; Bryan M Langholz; John Zadnick; Ann S Hamilton; Wendy Cozen; Thomas M Mack; Myles G Cockburn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-20       Impact factor: 4.254

Review 4.  State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now.

Authors:  Mary K Tripp; Meg Watson; Sophie J Balk; Susan M Swetter; Jeffrey E Gershenwald
Journal:  CA Cancer J Clin       Date:  2016-05-27       Impact factor: 508.702

Review 5.  Dysplastic nevi and melanoma.

Authors:  Alisa M Goldstein; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

6.  Effects of web-based intervention on risk reduction behaviors in melanoma survivors.

Authors:  Deborah J Bowen; Wylie Burke; Jennifer L Hay; Hendrika Meischke; Julie N Harris
Journal:  J Cancer Surviv       Date:  2014-11-26       Impact factor: 4.442

Review 7.  Reflectance confocal microscopy of skin in vivo: From bench to bedside.

Authors:  Milind Rajadhyaksha; Ashfaq Marghoob; Anthony Rossi; Allan C Halpern; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2016-10-27       Impact factor: 4.025

8.  Awareness, Attitude, and Adherence to Preventive Measures in Patients at High Risk of Melanoma. A Cross-Sectional Study on 185 Patients.

Authors:  Marta Bertolin; Maria C Cercatto; Celia Requena; Carlos Serra-Guillen; Beatriz Llombart; Onofre Sanmartin; Carlos Guillen; Eduardo Nagore
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

9.  Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.

Authors:  Deborah J Bowen; Jennifer Hay; Hendrika Meischke; Joni A Mayer; Julie Harris-Wai; Wylie Burke
Journal:  Cancer Causes Control       Date:  2018-11-27       Impact factor: 2.506

Review 10.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.